Sungkanuparph S., Groger RK, Overton ET, Fraser VJ, Powderly WGPersistent low-level viraemia and virological failure in HIV-1-infected patients treated with highly active antiretroviral therapy. HIV Med. 2006;7: 437-441.
2.
US Department of Health and Human Services.Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. Available at: http://aidsinfo.nih.gov/ContentFiles/AboutHIVTreatmentGuidelines_FS_en.pdf . Accessed September 14, 2008.
3.
Hammer S., Saag M., Schechter M., et al. Treatment for adult HIV infection: 2006 recommendations of the international AIDS Society-USA Panel. JAMA. 2006;296: 827-843.
4.
Sturmer M., Dauer B., Moesch M., et al. Evolution of resistance mutations during low-level viral replication in HIV-1-infected patients treated with zidovudine/lamivudine/ abacavir as a first-line regimen. Antivir Ther. 2007;12: 25-30.
5.
Lafeuillade A. , Hittinger G., Delbeke E., Poggi C.Resistance selection in patients with stable low levels of HIV-1 viremia. Presented at: The 15th International AIDS conference; July 11-16, 2004; Bangkok, Thailand. Abstract WeOrB1293.
6.
Cozzi-Lepri A., Philips AN, Ruiz L., et al. Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen. AIDS. 2007;21:721-732.
